|
|
||||||||

,
,
,
,
,

,
* Department of Internal Medicine, Renmin Hospital, Wuhan University, and
Department of Immunology and
Laboratory of Allergy and Clinical Immunology, Institute of Allergy and Immune-Related Diseases and Center for Medical Research, Wuhan University School of Medicine, and
Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Peoples Republic of China; and
¶ Department of Immunology, Fourth Military Medical University, Xian, Peoples Republic of China
Humans and mice with systemic lupus erythematosus (SLE) and related autoimmune diseases have reduced numbers of NK T cells. An association between NK T cell deficiency and autoimmune disease has been identified. However, the mechanisms for reduction of NK T cell number in patients with SLE are unknown. In the present study we report that NK T cells from active SLE patients are highly sensitive to anti-CD95-induced apoptosis compared with those from normal subjects and inactive SLE patients. CD226 expression is deficient on NK T cells from active SLE patients. The expression of one antiapoptotic member protein, survivin, is found to be selectively deficient in freshly isolated NK T cells from active SLE patients. CD226 preactivation significantly up-regulates survivin expression and activation, which can rescue active SLE NK T cells from anti-CD95-induced apoptosis. In transfected COS7 cells, we confirm that anti-CD95-mediated death signals are inhibited by activation of the CD226 pathway through stabilization of caspase-8 and caspase-3 and through activation of survivin. We therefore conclude that deficient expression of CD226 and survivin in NK T cells from active SLE is a molecular base of high sensitivity of the cells to anti-CD95-induced apoptosis. These observations offer a potential explanation for high apoptotic sensitivity of NK T cells from active SLE, and provide a new insight into the mechanism of reduction of NK T cell number in SLE and understanding the association between NK T cell deficiency and autoimmune diseases.
This article has been cited by other articles:
![]() |
V. PARIETTI, H. CHIFFLOT, S. MULLER, and F. MONNEAUX Regulatory T Cells and Systemic Lupus Erythematosus Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 64 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Jian, C.-S. Zhu, Z.-W. Xu, W.-M. Ouyang, D.-C. Ma, Y. Zhang, L.-J. Chen, A.-G. Yang, and B.-Q. Jin Identification and Characterization of the CD226 Gene Promoter J. Biol. Chem., September 29, 2006; 281(39): 28731 - 28736. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sen, B. Yongyi, H. Yuling, X. Luokun, H. Li, X. Jie, D. Tao, Z. Gang, L. Junyan, H. Chunsong, et al. V{alpha}24-Invariant NKT Cells from Patients with Allergic Asthma Express CCR9 at High Frequency and Induce Th2 Bias of CD3+ T Cells upon CD226 Engagement J. Immunol., October 15, 2005; 175(8): 4914 - 4926. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Blank and Y. Shoenfeld Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus Rheumatology, September 1, 2005; 44(9): 1086 - 1089. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |